Page last updated: 2024-10-15

acetylcarnitine and Spinal Muscular Atrophies of Childhood

acetylcarnitine has been researched along with Spinal Muscular Atrophies of Childhood in 2 studies

Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.

Spinal Muscular Atrophies of Childhood: A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wadman, RI2
Bosboom, WM2
van den Berg, LH2
Wokke, JH2
Iannaccone, ST2
Vrancken, AF2
van der Pol, WL1

Reviews

2 reviews available for acetylcarnitine and Spinal Muscular Atrophies of Childhood

ArticleYear
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids;

2011
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids;

2012